Choi Sungmi, Kim Kwan Woo, Ku Keun Bon, Kim Seong-Jun, Park Changwoo, Park Dongju, Kim Seil, Yi Hana
Interdisciplinary Program in Precision Public Health, Korea University, Seoul, South Korea.
Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, South Korea.
Front Microbiol. 2022 Mar 25;13:789665. doi: 10.3389/fmicb.2022.789665. eCollection 2022.
Rapid and accurate sequencing covering the entire genome is essential to identify genetic variations of viral pathogens. However, due to the low viral titers in clinical samples, certain amplification steps are required for viral genome sequencing. At present, there are no universal primers available for alphacoronaviruses and that, since these viruses have diverse strains, new primers specific to the target strain must be continuously developed for sequencing. Thus, in this study, we aimed to develop a universal primer set valid for all human alphacoronaviruses and applicable to samples containing trace amounts of the virus. To this aim, we designed overlapping primer pairs capable of amplifying the entire genome of all known human alphacoronaviruses. The selected primers, named the AC primer set, were composed of 10 primer pairs stretching over the entire genome of alphacoronaviruses, and produced PCR products of the expected size (3-5 kb) from both the HCoV-229E and HCoV-NL63 strains. After genome amplification, an evaluation using various sequencing platforms was carried out. The amplicon library sequencing data were assembled into complete genome sequences in all sequencing strategies examined in this study. The sequencing accuracy varied depending on the sequencing technology, but all sequencing methods showed a sequencing error of less than 0.01%. In the mock clinical specimen, the detection limit was 10 PFU/ml (10 copies/ml). The AC primer set and experimental procedure optimized in this study may enable the fast diagnosis of mutant alphacoronaviruses in future epidemics.
覆盖整个基因组的快速准确测序对于识别病毒病原体的基因变异至关重要。然而,由于临床样本中的病毒滴度较低,病毒基因组测序需要某些扩增步骤。目前,还没有适用于甲型冠状病毒的通用引物,而且由于这些病毒具有多种毒株,必须不断开发针对目标毒株的新引物用于测序。因此,在本研究中,我们旨在开发一套对所有人类甲型冠状病毒均有效的通用引物组,并适用于含有微量病毒的样本。为此,我们设计了能够扩增所有已知人类甲型冠状病毒全基因组的重叠引物对。所选引物命名为AC引物组,由10对引物组成,覆盖甲型冠状病毒的整个基因组,并且从HCoV - 229E和HCoV - NL63毒株均产生了预期大小(3 - 5 kb)的PCR产物。基因组扩增后,使用各种测序平台进行了评估。在本研究中检测的所有测序策略中,扩增子文库测序数据均被组装成完整的基因组序列。测序准确性因测序技术而异,但所有测序方法的测序错误率均小于0.01%。在模拟临床标本中,检测限为10 PFU/ml(10拷贝/ml)。本研究中优化的AC引物组和实验程序可能有助于在未来疫情中快速诊断甲型冠状病毒突变体。